Expression of annexin A1 mRNA in peripheral blood from oral squamous cell carcinoma patients

Oral Oncology

Volumn 46, Issue 1, 2010, Pages 25-30

  Faria, Paula Cristina Batista ^a   Sena, Angela Aparecida Servino ^a   Nascimento, Rafael ^a   Carvalho, Washington João ^a   Loyola, Adriano Mota ^a   Silva, Sindeval José ^a   Durighetto Jr , Antônio Francisco ^a   Oliveira Jr , Anísio Domingos ^a   Oliani, Sonia Maria ^b   Goulart, Luiz Ricardo ^a  

^a FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Annexin A1; Blood biomarker; Oral squamous cell carcinoma; Real time PCR

Indexed keywords

ANTINEOPLASTIC AGENT; LIPOCORTIN 1; MESSENGER RNA;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; LIP CARCINOMA; MALE; MOUTH CARCINOMA; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; REAL TIME POLYMERASE CHAIN REACTION; SEX DIFFERENCE; SQUAMOUS CELL CARCINOMA; TUMOR LOCALIZATION;

AGED; ANNEXIN A1; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; LIP NEOPLASMS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM PROTEINS; RNA, MESSENGER; ROC CURVE;

EID: 72449165357     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2009.09.003     Document Type: Article

References (32)

1. Khanna S.S., and Karjodkar F.R. Circulating immune complexes and trace elements (Copper, Iron and Selenium) as markers in oral precancer and cancer: a randomised, controlled clinical trial. Head Face Med 2 (2006) 33
2. Zhang L., Yang X., Zhong L.P., Zhou X.J., Pan H.Y., Wei K.J., et al. Decreased expression of Annexin A1 correlates with pathologic differentiation grade in oral squamous cell carcinoma. J Oral Pathol Med 38 4 (2009) 362-370
3. Kesting M.R., Sudhoff H., Hasler R.J., Nieberler M., Pautke C., Wolff K.D., et al. Psoriasin (S100A7) up-regulation in oral squamous cell carcinoma and its relation to clinicopathologic features. Oral Oncol 45 8 (2009) 731-736
4. Scully C., and Bagan J. Oral squamous cell carcinoma overview. Oral Oncol 45 4-5 (2009) 301-308
5. Shah NG, Trivedi TI, Tankshali RA, Goswami JV, Jetly DH, Shukla SN, et al. Prognostic significance of molecular markers in oral squamous cell carcinoma: a multivariate analysis. Head Neck 2009. in press.
6. Hassan N.M., Tada M., Hamada J., Kashiwazaki H., Kameyama T., Akhter R., et al. Presence of dominant negative mutation of TP53 is a risk of early recurrence in oral cancer. Cancer Lett 270 1 (2008) 108-119
7. Vishwanatha J.K., Swinney R., and Banerjee A.G. Modulation of annexin I and cyclooxygenase-2 in smokeless tobacco-induced inflammation and oral cancer. Mol Cell Biochem 248 1-2 (2003) 67-75
8. Perretti M., and Flower R.J. Annexin 1 and the biology of the neutrophil. J Leukoc Biol 76 1 (2004) 25-29
9. Kamal A.M., Flower R.J., and Perretti M. An overview of the effects of annexin 1 on cells involved in the inflammatory process. Mem Inst Oswaldo Cruz 100 1 (2005) 39-48
10. Lim L.H., and Pervaiz S. Annexin 1: the new face of an old molecule. FASEB J 21 4 (2007) 968-975
11. Perretti M., and D'Acquisto F. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat Rev Immunol 9 1 (2009) 62-70
12. Kang J.S., Calvo B.F., Maygarden S.J., Caskey L.S., Mohler J.L., and Ornstein D.K. Dysregulation of annexin I protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer. Clin Cancer Res 8 1 (2002) 117-123
13. Hayes M.J., and Moss S.E. Annexins and disease. Biochem Biophys Res Commun 322 4 (2004) 1166-1170
14. Sena A.A., Provazzi P.J., Fernandes A.M., Cury P.M., Rahal P., and Oliani S.M. Spatial expression of two anti-inflammatory mediators, annexin 1 and galectin-1, in nasal polyposis. Clin Exp Allergy 36 10 (2006) 1260-1267
15. Sawmynaden P., and Perretti M. Glucocorticoid upregulation of the annexin-A1 receptor in leukocytes. Biochem Biophys Res Commun 349 4 (2006) 1351-1355
16. Silistino-Souza R., Rodrigues-Lisoni F.C., Cury P.M., Maniglia J.V., Raposo L.S., Tajara E.H., et al. Annexin 1: differential expression in tumor and mast cells in human larynx cancer. Int J Cancer 120 12 (2007) 2582-2589
17. Li Y., Elashoff D., Oh M., Sinha U., St John M.A., Zhou X., et al. Serum circulating human mRNA profiling and its utility for oral cancer detection. J Clin Oncol 24 11 (2006) 1754-1760
18. Sidransky D. Nucleic acid-based methods for the detection of cancer. Science 278 5340 (1997) 1054-1059
19. Sobin L.H., and Wittekind C.H. International union against cancer (UICC) TNM classification of malignant tumours. 6th ed. (2002), New York, Wiley p. 22-6
20. Barnes L., Everson J.W., and Reichart P. World health organisation classification of tumours pathology and genetics of head and neck tumours (2005), Lyon, JARC Press p. 168-175
21. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 1 (1987) 156-159
22. Morand E.F., Hutchinson P., Hargreaves A., Goulding N.J., Boyce N.W., and Holdsworth S.R. Detection of intracellular lipocortin 1 in human leukocyte subsets. Clin Immunol Immunopathol 76 2 (1995) 195-202
23. D'Acquisto F., Merghani A., Lecona E., Rosignoli G., Raza K., Buckley C.D., et al. Annexin-1 modulates T-cell activation and differentiation. Blood 109 3 (2007) 1095-1102
24. Rondepierre F., Bouchon B., Papon J., Bonnet-Duquennoy M., Kintossou R., Moins N., et al. Proteomic studies of B16 lines: involvement of annexin A1 in melanoma dissemination. Biochim Biophys Acta 1794 1 (2009) 61-69
25. Goldenberg D., Brooksby C., and Hollenbeak C.S. Age as a determinant of outcomes for patients with oral cancer. Oral Oncol 45 8 (2009) e57-e61
26. Papageorge M. Etiology of oral cancer in the young patient: is tongue cancer becoming the other cancer in women?. Oral Maxillofac Surg Clin North Am 19 2 (2007) 163-171
27. Curado M.P., and Hashibe M. Recent changes in the epidemiology of head and neck cancer. Curr Opin Oncol 21 3 (2009) 194-200
28. Hsiang C.H., Tunoda T., Whang Y.E., Tyson D.R., and Ornstein D.K. The impact of altered annexin I protein levels on apoptosis and signal transduction pathways in prostate cancer cells. Prostate 66 13 (2006) 1413-1424
29. Alldridge L.C., and Bryant C.E. Annexin 1 regulates cell proliferation by disruption of cell morphology and inhibition of cyclin D1 expression through sustained activation of the ERK1/2 MAPK signal. Exp Cell Res 290 1 (2003) 93-107
30. Arur S., Uche U.E., Rezaul K., Fong M., Scranton V., Cowan A.E., et al. Annexin I is an endogenous ligand that mediates apoptotic cell engulfment. Dev Cell 4 4 (2003) 587-598
31. Scannell .M., Flanagan M.B., de Stefani A., Wynne K.J., Cagney G., Godson C., et al. Annexin-1 and peptide derivatives are released by apoptotic cells and stimulate phagocytosis of apoptotic neutrophils by macrophages. J Immunol 178 7 (2007) 4595-4605
32. Besse F., and Ephrussi A. Translational control of localized mRNAs: restricting protein synthesis in space and time. Nat Rev Mol Cell Biol 9 12 (2008) 971-980